Literature DB >> 21333435

Influence of birth mode on early neurological outcome in infants with myelomeningocele.

Inge Cuppen1, Alex J Eggink, Fred K Lotgering, Jan J Rotteveel, Reinier A Mullaart, Nel Roeleveld.   

Abstract

OBJECTIVE: The aim of the study was to determine whether route of birth affects early neurological outcome in infants with myelomeningocele. STUDY
DESIGN: In a retrospective cohort study, 95 neonates with myelomeningocele evaluated at the Radboud University Nijmegen Medical Centre between 1990 and 2006 were reviewed. The effect of delivery mode on early neurological outcome was assessed as the difference between the functional neurological level of the defect and the X-ray level (ΔFAX).
RESULTS: Early neurological outcome was better in the vaginally delivered infants (ΔFAX 0.96 ± 2.1) than in those delivered by cesarean section (ΔFAX 0.20 ± 2.5). After correction for confounders, multiple regression analysis demonstrated that vaginal delivery was associated with significantly better early neurological outcome as compared to cesarean section (β=1.21; 95% CI 0.16; 2.27; p=0.03) for infants in vertex and breech position combined. Subgroup analysis revealed a non-significant trend towards better outcome after vaginal delivery that was more pronounced in infants in breech position than in vertex position.
CONCLUSION: In infants with myelomeningocele, born in either vertex or breech position, there is no clinical evidence that early neurological outcome is improved by cesarean section.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21333435     DOI: 10.1016/j.ejogrb.2011.01.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  Mortality by mode of delivery among infants with spina bifida in Texas.

Authors:  Renata H Benjamin; Adriana Lopez; Laura E Mitchell; KuoJen Tsao; Anthony Johnson; Peter H Langlois; Michael D Swartz; A J Agopian
Journal:  Birth Defects Res       Date:  2019-10-23       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.